News brief­ing: In­cyte bankrolls an ear­ly-stage myelofi­bro­sis pair-up with Jakafi; In­no­Care gets Chi­nese ap­proval for lead drug

Look­ing to fur­ther bol­ster its block­buster fran­chise for Jakafi, In­cyte has struck a deal to part­ner up on a new com­bi­na­tion ap­proach to treat­ing myelofi­bro­sis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER